MedStar Health Blog

About 1 in 8 men will develop prostate cancer in their lifetime, making it the most common cancer in men. About 70% of prostate cancers are diagnosed early, before the cancer spreads, when it is easi...

The FDA recently approved a new targeted therapy for certain lung and pancreatic cancers, based on a global trial involving our academic health system partner Georgetown Lombardi Comprehensive Cancer...

While the exact function of the appendix remains unclear, some studies suggest it may play a role in gut immunity or in maintaining healthy gut bacteria. However, it is often referred to as a 'vestig...

Learning you have an uncommon type of cancer, such as a sarcoma, can create a lot of questions: How are sarcomas diagnosed? What are the treatment options? Will I lose my arm or leg? Our collaborativ...

CyberKnife can treat prostate cancer in as few as five visits, making it a convenient, effective treatment option for many men.

Read More

Almost half of people with metastatic melanoma—a type of skin cancer that has spread beyond the skin—can become resistant to standard treatments. A new immunotherapy available at MedStar ...